Bromopride

CAS : 4093-35-0

Ref. 3D-FB19308

Informations sur le produit

• Nom: Bromopride
• Synonymes: 4-Amino-5-bromo-N-[2-(diethylamino)ethyl]-2-methoxybenzamide2-Methoxy-4-amino-5-bromo-N,N-diethylaminoethylbenzamideN-Diethylamino ethyl-2-methoxy-4-amino-5-bromobenzamide, 2-Methoxy-4-amino-5-bromo-N,N-diethylaminoethylbenzamide, 4-Amino-5-bromo-N-(2-(diethylamino)ethyl)-o-anisamide, 4-amino-5-bromo-N-[2-(diethylamino)ethyl]-2-methoxybenzamide, Artomey, Benzamide, 4-amino-5-bromo-N-(2-(diethylamino)ethyl)-2-methoxy- (9CI), Benzamide, 4-amino-5-bromo-N-[2-(diethylamino)ethyl]-2-methoxy-, Brn 2381893, Bromoprida, Bromoprida [INN-Spanish], Bromoprida [Spanish], Bromopride [INN:DCF], Bromopridum, Bromopridum [INN-Latin], Emepride, Emoril, N-(Diethylaminoethyl)-2-methoxy-4-amino-5-bromobenzamide, Unii-75473V2Yzk, Val 13081, Valopride, Viadil, o-Anisamide, 4-amino-5-bromo-N-(2-(diethylamino)ethyl)-
• CAS: 4093-35-0

Description

Bromopride is a drug that belongs to the group of antirheumatic drugs, which are used for the treatment of symptoms such as pain, swelling, and stiffness in joints. Bromopride inhibits the cb2 receptor and the adenosine receptor antagonist. It also has an intramolecular hydrogen bond with the dopamine molecule. This drug has been shown to be effective against vasoactive intestinal peptide-induced rat paw edema. Bromopride is not active against dopamine-induced rat paw edema or tnf-α-induced rat paw edema.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 344.25 g/mol
• Formule: C₁₄H₂₂BrN₃O₂
• Degré de pureté: Min. 95%
• InChI: InChI=1S/C14H22BrN3O2/c1-4-18(5-2)7-6-17-14(19)10-8-11(15)12(16)9-13(10)20-3/h8-9H,4-7,16H2,1-3H3,(H,17,19)
• Code InChI: InChIKey=GIYAQDDTCWHPPL-UHFFFAOYSA-N
• SMILES: CCN(CC)CCNC(=O)c1cc(Br)c(N)cc1OC